1-5 of 5
Alessandra Bertola
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome

Clinical Trials & Observations
Marco Ladetto, Sonia Vallet, Andreas Trojan, Maria Dell'Aquila, Luigia Monitillo, Rosalba Rosato, Loredana Santo, Daniela Drandi, Alessandra Bertola, Patrizia Falco, Federica Cavallo, Irene Ricca, Federica De Marco, Barbara Mantoan, Beata Bode-Lesniewska, Gloria Pagliano, Roberto Francese, Alberto Rocci, Monica Astolfi, Mara Compagno, Sara Mariani, Laura Godio, Lydia Marino, Marina Ruggeri, Paola Omedè, Antonio Palumbo, Mario Boccadoro
Journal: Blood
Blood (2005) 105 (12): 4784–4791.
https://doi.org/10.1182/blood-2004-11-4201
Published: 2005
Journal Articles

Thalidomide and Dexamethasone Is an Effective Salvage Regimen for Myeloma Patients Relapsing after Autologous Transplant.

Antonio Palumbo, MD, Patrizia Falco, MD, Maria Teresa Ambrosini, MD, Tommaso Caravita, MD, Pellegrino Musto, MD, Maria Teresa Petrucci, MD, Patrizia Pregno, MD, Ilaria Avonto, MD, Alessandra Bertola, MD, Sara Bringhen, MD, Federica Cavallo, MD, Giovannino Ciccone, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2004) 104 (11): 2396.
https://doi.org/10.1182/blood.V104.11.2396.2396
Published: 2004
Journal Articles

Cyclooxygenase-2 (COX-2) Is Frequently Expressed in Multiple Myeloma (MM) and Is Associated with Poor Outcome.

Marco Ladetto, Sonia Vallet, Andreas Trojan, Maria Dell’Aquila, Luigia Monitillo, Loredana Santo, Alessandra Bertola, Patrizia Falco, Federica Cavallo, Daniela Drandi, Irene Ricca, Gloria Pagliano, Monica Astolfi, Alberto Rocci, Beata Bode, Antonio Palumbo, Corrado Tarella, Paola Omedé, Mario Boccadoro
Journal: Blood
Blood (2004) 104 (11): 2450.
https://doi.org/10.1182/blood.V104.11.2450.2450
Published: 2004
Journal Articles

A Prospective Randomized Trial of Oral Melphalan, Prednisone, Thalidomide (MPT) vs Oral Melphalan, Prednisone (MP): An Interim Analysis.

Antonio Palumbo, MD, Alessandra Bertola, MD, Pellegrino Musto, MD, Tommaso Caravita, MD, Vincenzo Callea, MD, Clotilde Cangialosi, MD, Anna Marina Liberati, MD, Pasquale Niscola, MD, Lucio Catalano, MD, Mariella Grasso, MD, Vito Michele Lauta, MD, Maria Concetta Petti, MD, Sergio Morandi, MD, Monica Galli, MD, Sara Bringhen, MD, Federica Cavallo, MD, Patrizia Falco, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2004) 104 (11): 207.
https://doi.org/10.1182/blood.V104.11.207.207
Published: 2004
Journal Articles

Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial

Clinical Trials & Observations
Antonio Palumbo, Sara Bringhen, Maria Teresa Petrucci, Pellegrino Musto, Fausto Rossini, Martina Nunzi, Vito Michele Lauta, Cesare Bergonzi, Anna Barbui, Tommaso Caravita, Antonio Capaldi, Patrizia Pregno, Tommasina Guglielmelli, Mariella Grasso, Vincenzo Callea, Alessandra Bertola, Federica Cavallo, Patrizia Falco, Cecilia Rus, Massimo Massaia, Franco Mandelli, Angelo Michele Carella, Enrico Pogliani, Anna Marina Liberati, Franco Dammacco, Giovannino Ciccone, Mario Boccadoro
Journal: Blood
Blood (2004) 104 (10): 3052–3057.
https://doi.org/10.1182/blood-2004-02-0408
Published: 2004